[This review was originally posted at the Nieman Journalism Lab Bactrim Price, on April 29, 2011.]
Leaking gets competitive: WikiLeaks made its first major document release in five months — during which time its founder, Julian Assange, was arrested, released on bail, and put under house arrest — this week, publishing 764 files regarding the Guantánamo Bay prison along with 10 media partners. (As always, The Nation's Greg Mitchell's WikiLeaks über-blogging is the place to go for every detail you could possibly need to know.)
That's more media partners than WikiLeaks has worked with previously, and it includes several first-timers, such as the Washington Post and McClatchy. As the Columbia Journalism Review's Joel Meares noted, Where can i buy Bactrim online, the list of partners doesn't include the New York Times and the Guardian, the two English-language newspapers who worked with WikiLeaks in its first media collaboration last summer. Despite being shut out, those two organizations were still able to force WikiLeaks' hand in publishing the leak, as the Huffington Post's Michael Calderone explained.
The Times got their hands on the documents independently, then passed them on to the Guardian and NPR, order Bactrim no prescription. This meant that, unlike the news orgs that got the info from WikiLeaks, they were operating without an embargo, Bactrim Price. As they prepared to publish last Sunday, WikiLeaks lifted its embargo early for its own partners (though the first to publish was actually the Telegraph, a WikiLeaks partner).
The New York Times' Brian Stelter and Noam Cohen said the episode was evidence that WikiLeaks "has become such a large player in journalism that some of its secrets are no longer its own to control." But, as they reported, Bactrim photos, WikiLeaks itself didn't seem particularly perturbed about it.
Patch's reaches for more bloggers: AOL seems to be undergoing a different overhaul every week since it bought the Huffington Post earlier this year, and this week the changes are at its hyperlocal initiative Patch, which is hoping to add 8,000 community bloggers to its sites over the next week or two in what its editor-in-chief called a "full-on course correction."
While talking to paidContent, AOL's folks played down the degree of change it's implementing, explaining that these new bloggers (who will be recruited from, Bactrim recreational, among other sources, the sites' frequent commenters) aren't disrupting the basic Patch model of one full-time editor per site. In fact, they'll be unpaid, something that's been a bit of a headache for AOL and HuffPo lately.
Business Insider's Nicholas Carlson liked the plan Bactrim Price, , saying volunteer bloggers can become "extremely effective word-of-mouth marketers" and "excellent pageview machines" with, of course, "manageable" salaries. Bactrim class, Others from MediaBistro and Wired were a little more skeptical of the no-pay factor. Lehigh j-prof Jeremy Littau took issue with a more systemic aspect of the new blogs, which will exist both on the writer's own site and on Patch. Splitting up the conversation with that arrangement won't be helpful for the individual blogs or for the local blogosphere as a whole, he said: "I see something developing that leads to less population in the local blogosphere and a walled-off system that operates on Patch. At worst, it will lead to parallel and fracture conversations online, which is death when we’re talking about hyperlocal."
Two new media manifestos: Two New York j-profs — and two of the more prominent future-of-news pundits online these days — both published manifestos of sorts this week, effects of Bactrim, and both are worth a read. Jay Rosen summed up what he's learned about journalism in 25 years of teaching and thinking about it at NYU, and CUNY's Jeff Jarvis gave a few dozen bullet points outlining his philosophy of news economics.
Rosen's post touched on several of the themes that have colored his blog and Twitter feed over the past few years, including the value of increasing participation, the failure of "objectivity," and the need for usefulness and context in news, Bactrim Price. But the ideas weren't exactly new, the conversation they generated was stimulating. Bactrim interactions, The comments chase down some interesting tangents, and GigaOM's Mathew Ingram expanded on Rosen's point about participation, arguing that even if the number of users who want to participate is relatively low, opening up the process can still be immensely important in improving journalism. Rosen also inspired TBD's Steve Buttry to write his own "what I know about news" post.
Like Rosen's post, Jarvis' wouldn't break a whole lot of ground for those already familiar with his ideas, my Bactrim experience, but it summed them up in a helpfully pithy format. Bactrim Price, He focused heavily on providing real value ("The only thing that matters to the market is value"), the importance of engagement, and finding efficiencies in infrastructure and collaboration. His post contains plenty of pessimism about the current newspaper business model, and Mathew Ingram and FishbowlNY's Chris O'Shea defended him against the idea that he's just a doomsayer.
Times paywall bits: The New York Times spent a reported $25 million to develop its paid-content system, and it will be spending another $13 million on the plan this year, Bactrim without prescription, mostly for promotion. Women's Wear Daily detailed those promotional efforts, which include posters around New York as well as TV spots. PaidContent's Robert Andrews compared the Times' pay plan to that of theother Times (the one in London, owned by Rupert Murdoch), noting that the New York Times' plan should allow them to draw more revenue while maintaining their significant online influence, something the Times of London hasn't done at all (though it's largely by choice), Bactrim from canadian pharmacy.
Meanwhile, Terry Heaton found another (perhaps more convoluted) way around the Times' system, tweeting links to Times stories that he can't access, Bactrim Price. And elsewhere at the Times, the Lab's Megan Garber explored the Times' R&D Lab's efforts to map the way Times stories are shared online.
And elsewhere in paywalls, the CEO of the McClatchy newspaper chain has reversed his anti-paywall stance and said this week the company is planning paywalls for some of its larger papers, and Business Insider introduced us to another online paid-content company, Buy Bactrim online no prescription, Tiny Pass.
Apps, news, and pay: In his outgoing post on Poynter's Mobile Media blog, Damon Kiesow had a familiar critique for news organizations' forays into mobile media — they're too much like their print counterparts to be truly called innovative. But he did add a reason for optimism, pointing to the New York Times' News.me and the Washington Post's Trove: "Neither is a finished product or a perfect one, get Bactrim. But both were created by newspaper companies that put resources into research and development."
Media analyst Ken Doctor said Bactrim Price, local news needs to start moving toward mobile media to reach full effectiveness, laying out the model of an aggregated local news app pulling various types of media. For maximum engagement, that app had better include audio, according to some NPR statistics reported by the Lab's Andrew Phelps.
There may a bigger place for paid apps than we've thought: Instapaper's Marco Arment twice pulled the free version of the app for about a month and found that sales actually increased. He made the case against free apps, Kjøpe Bactrim på nett, köpa Bactrim online, saying they bring low conversion rates, little revenue, and unnecessary image problems. Meanwhile, makers of one free app, Zite, said they're releasing a new version to deal with complaints they've been getting from publishers about copyright issues, about Bactrim.
Reading roundup: No big stories this week, but tons of little things to keep up on, Bactrim Price. Here's a bit of the basics:
— On social media: Facebook launched a "Send" plugin among a few dozen websites (including a couple of news sites) that allows private content-sharing. The Next Web's Lauren Fisher argued that journalists should spend more time using Facebook, and Canadian j-prof Alfred Hermida wrote about a study he helped conduct about social media and news consumption.
— The Guardian shut down a local-news project it launched last year, saying the local blogs were "not sustainable." PaidContent's Robert Andrews said that while the blogs were useful, Bactrim cost, there are few examples of sustainable local-news efforts, and Rachel McAthy of Journalism.co.uk rounded up some opinions to try to find the value in the Guardian's experiment.
— The news filtering program launched in public beta this week, prompting a New York Times profile and pieces by GigaOM's Mathew Ingram and the Knight Digital Media Center's Amy Gahran on the journalistic value of curation.
— Thanks to its most recent content-farm-oriented algorithm tweak, Google's traffic to all Demand Media sites is down 40%, which caused Demand stock to slide this week. Google, meanwhile, added some more automatic personalization features to Google News.
— The Lab's Andrew Phelps wrote a great piece expounding on the journalistic utility of the humble (well, kind of humble) smartphone.
— And for your deep-thinking weekend-reading piece, Harvard researcher Ethan Zuckerman's thoughtful take on overcoming polarization by understanding each other's values, rather than just facts.
Similar posts: Flagyl Price. Order Zoloft. Purchase Tramadol. Buy Cephalexin online cod. Cephalexin long term. Cipro use.
Trackbacks from: Bactrim Price. Bactrim Price. Bactrim Price. Bactrim natural. Buy Bactrim without a prescription. Doses Bactrim work.
[This review was originally posted at the Nieman Journalism Lab Armour For Sale, on Jan. 28, 2011.]
Playing WikiLeaks Whack-a-Mole: Ever since WikiLeaks broke through into the public's consciousness last summer, observers have been predicting that its functions would be replicated by other organizations, both within and outside traditional journalism. We've seen signs of that for a couple of months, but the movement toward leakiness got a few big boosts this week with the launch of a leak submission system by Al Jazeera and the news that The New York Times is considering one of its own, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release.
Al Jazeera started off with the release of the Palestine Papers, and the Palestinian Authority responded by blocking the new site. The Times' executive editor, Bill Keller, said his paper's looking at something along the lines of Al Jazeera's system, Cheap Armour, and a group from the CUNY Graduate School is also launching Localeaks, which allows leakers to submit leaks to any one of more than 1,400 local newspapers in the U.S. Meanwhile, WikiLeaks' Julian Assange told the Associated Press that he's up to 20 media partners and is hoping to triple that number in the next few months, Armour For Sale.
A couple of writers weighed in with thoughtful takes on these developments: Mathew Ingram of GigaOM suggested that leakers might still prefer WikiLeaks because it allows them freedom from relying on only one organization's view of the documents, since WikiLeaks works with numerous competing news outlets. In a particularly insightful piece, Raffa Khatchadourian of The New Yorker expounded on the strengths and weaknesses of the traditional media alternative to WikiLeaks, buy cheap Armour no rx, focusing on the two organizations' ties to societal conventions: "accountability limits the Times, but it also offers it protections—protections that WikiLeaks at the moment does not enjoy because, among other things, there is not enough public consensus on what it is and stands for."
That chasm between the culture of the Times and WikiLeaks was vividly manifested this week with the Times' publication of an essay by Keller about his paper's dealings with WikiLeaks, painting a less-than-flattering picture of Assange. Order Armour online overnight delivery no prescription, (The Daily Beast and Yahoo News have good summaries of the piece.) WikiLeaks denounced the article, and Gawker's John Cook found Keller's insults off-putting, especially given the service Assange has done his paper. Cook also pointed out the degree to which the Times worked with the U.S. Armour For Sale, State Department in releasing the cables, a practice that's probably quite at odds with Assange's theory of radical transparency.
Ongo's paid aggregation plan: Few topics are hotter in the future-of-news world than aggregation, except perhaps for the ongoing quest to find a way to make money off of news online. So when a startup combines both, Armour class, like Ongo is doing, people are going to pay attention. The service, launched this week by eBay/Skype/PayPal alum Alex Kazim, offers aggregated news from several major news outlets for fees starting at $6.99 a month. Armour from canada, Kazim told paidContent that he's targeting users who graze among numerous news sites and value a sharp user experience more highly than the content itself.
The instant reviews weren't exactly enthusiastic, Armour For Sale. Mashable's Lauren Indvik said that Ongo's slim selection of news outlets will likely leave users getting only a fraction of their daily news via Ongo — something they may not be willing to pay for. (Andrew Edgecliffe-Johnson of the Financial Times made a similar argument.) Zee Kane of The Next Web said Flipboard, Feedly and Google Reader all provide similar services, and they're all cheaper and better. Lost Remote's Cory Bergman compared Ongo with Hulu's model, but noted that Hulu's product (entertainment TV) is scarcer and more highly demanded than Ongo's product (online news), Armour mg.
GigaOM's Mathew Ingram had the harshest criticism, arguing that no one who knows how to use RSS will have any reason to use Ongo."Ongo seems like yet another Hail Mary pass aimed at trying to rewind the clock and impose scarcity on media content, and one that will likely fail just as quickly as others have," he wrote. Armour For Sale, But there is one group of people who have quite a bit of faith in Ongo — newspaper executives, particularly those from The New York Times, The Washington Post, and Gannett, all of whom have invested in the company. The Times, Armour pics, of course, is planning an online paid-content plan of its own, which The Wall Street Journal reported it will begin rolling out next month. According to the Journal, the Times' current plan has an iPad/web bundle costing more than twice as much as a website subscription alone, leading Reuters' Felix Salmon to wonder why the Times seems to be planning on pushing readers away from its iPad app.
Wall Street's warm welcome for Demand Media: Demand Media, cheap Armour no rx, the most prominent of the "content farms" that have drawn so much criticism over the past year or so, had an extraordinarily successful initial public offering on Wall Street this week, with first-day trading pushing its valuation to $1.5 billion Wednesday — higher than The New York Times Co. itself. That had to sting quite a bit for the Times, especially considering that, as Rafat Ali reported and The Wall Street Journal confirmed, the Times had almost bought Demand a few years back, Armour For Sale.
Demand's trading was driven by a lot of enthusiasm — exemplified by Keith Richman at Advertising Age — about the efficiency and profitability of its business model, Kjøpe Armour på nett, köpa Armour online, but its detractors are still loud, too. Forbes' Jeff Bercovici mocked some ridiculous Demand articles, and The Columbia Journalism Review's Lauren Kirchner told journalists why they should care: Demand is "a company that works every day to lower the standards of online content, that devalues the skills of reporting and writing, and that removes any incentive for original thought in exchange for quantity and speed."
Someone else who signaled its displeasure with companies like Demand this week: Google, on whom much of Demand's business model rests, Armour class. In a blog post, Google's Matt Cutts explained the shift in the company's antispam efforts toward a content-farm crackdown. Lauren Kirchner called spammers "tapeworms" for Google, but at Business Insider, Ben Elowitz argued that Google and Demand have a mutual (and mutually destructive) advertising-based relationship. Armour For Sale, Demand's Richard Rosenblatt, meanwhile, insisted that Cutts' post wasn't about Demand, and that the two companies have a healthy, "synergistic" relationship. Where can i buy cheapest Armour online, Search Engine Land's Danny Sullivan imagined what a Demand Media edition of The New York Times' website might look like, then urged news companies to both news coverage and "answers coverage" like the content farms — only a bit smarter.
Olbermann's exit: When MSNBC pundit Keith Olbermann ended his eight-year run hosting Countdown on Friday, it wasn't entirely unexpected — MSNBC suspended Olbermann in November for his contributions to Democratic candidates, touching off a simmering debate about objectivity and journalism. As The New York Times reported, Olbermann's exit was weeks in the making, Armour over the counter. Though its exact cause wasn't clear, Yahoo's Michael Calderone threw out a few possible reasons why Olbermann might have left.
In the wake of his departure, there was a bit of talk about Olbermann's place within the past decade of journalism: Lehigh j-prof Jeremy Littau said Olbermann's angry voice didn't fit the times anymore, though the Philadelphia Daily News' Will Bunch made a similar point in a more positive vein, suggesting Olbermann left because he had accomplished his mission giving voice to the appalled journalist and citizen, Armour For Sale. And Dave Winer urged Olbermann to now go directly to his audience, using the web to circumvent the traditional he just left.
Apple's subscription struggle: Apple's clampdown on publishers' hopes for subscriptions for the iPhone and iPad continues to ripple through the media world. Buy cheap Armour no rx, French analyst Frederic Filloux has a fantastic breakdown of the situation, explaining why publishers (especially smaller ones) are so upset and why they could take their app development elsewhere. ReadWriteWeb's Richard MacManus said the subscription plans would be good for consumers and publishers, but cautioned that it would put much of the business under Apple's control.
A few individual publishers' iPad developments: PaidContent gave us details of The Guardian's evolving plans Armour For Sale, for an iPad app, new publisher Nomad Editions launched four tablet-only magazines, and oh yeah, apparently Rupert Murdoch's coming out with some daily tablet-based news publication next week.
Reading roundup: A lot of big stories this week, so I'll go light on the ephemera:
— Last week's conversation (summarized nicely by David Cohn) about journalism education spilled over into this week. Tech pioneer Dave Winer provided this week's big idea with a great post on educating the "journo-programmer" (published in condensed form at the Lab), buy Armour online cod. Among his ideas: Teach aggregation, get away from the hackathon model, and just start doing it. PBS MediaShift profiled a innovative journalism program with which Winer is affiliated — Jay Rosen's Studio 20 at NYU.
— Your deep thought on the web for the week: Tech luminary John Battelle on the need for a new, revealed identity online.
— On the media literacy front, Paul Bradshaw, a j-prof at City University London and Birmingham City University, wrote a fantastic guide to verifying information online, focusing on content, context, and code.
— And in case you were wondering just what the heck is going on with the web right now, uh, The Oatmeal has you more than covered.
Similar posts: Synthroid Price. Order Tramadol. Retin A Cost. Retin A from mexico. Armour no prescription. Lipitor maximum dosage.
Trackbacks from: Armour For Sale. Armour For Sale. Armour For Sale. Armour schedule. Purchase Armour online. After Armour.
[This review was originally posted at the Nieman Journalism Lab Order Flagyl, on Jan. 14, 2011.]
Managing reporting errors in the river of news: Though Saturday's tragic shooting of Arizona Rep. Gabrielle Giffords was primarily a political story, it created several ripples that quickly spread into the media world. (One of those was the debate over our rather toxic climate of political rhetoric, though I'll leave that to other outlets to focus on.) Another issue, Generic Flagyl, more directly related to the future-of-news discussion, regarded how the news spread in the shooting's immediate aftermath.
As Lost Remote's Steve Safran described, several major news organizations, including Reuters, NPR, BBC News, and CNN, is Flagyl addictive, wrongly reported soon after the shooting that Giffords had died — reports that were corrected within a half-hour. NPR in particular devoted quite a bit of space to explaining its error, with social media editor Andy Carvin, ombudsman Alicia Shepard, and executive editor Dick Meyer all weighing in, Order Flagyl.
There was plenty of scrutiny from outside, too: Poynter's Mallary Jean Tenore called the mishap "understandable, but not excusable," and The Next Web's Chad Catacchio suggested that Twitter use editorial judgment to ensure that inaccurate information isn't highlighted in its Top Tweets. Salon's Dan Gillmor cited the situation as a reminder of Clay Shirky's line that "fact checking is down, Flagyl online cod, but after-the-fact checking is way up." Gillmor also posted an appropriate excerpt from his book, Mediactive, urging all of us to take a "slow news" approach to breaking news stories. Seattle TV journalist Paul Balcerak took the opportunity to remind both journalists and their audiences to ask "How do you know that?"
The erroneous tweets launched a parallel discussion on just what exactly to do with them: Leave them there. Delete them. Order Flagyl, Correct them. The debate began in the comments of Safran's Lost Remote post, with NPR's Carvin explaining why he left his faulty tweet as is. WBUR's Andrew Phelps explained why he made the same decision, Flagyl treatment, and ex-Saloner Scott Rosenberg defended both of them in two posts, suggesting a corrected retweet might offer a good compromise.
A couple of other new-media angles to the shooting's coverage: The Lab's Justin Ellis and Lost Remote's Cory Bergman looked at the awkward art of publicly making interview requests on Twitter, and Nieman Storyboard highlighted innovative storytelling approaches amid the shooting's chaotic aftermath.
Twitter's stand against secrecy: The ongoing WikiLeaks saga publicly roped in Twitter this week, as news broke of the U.S. Department of Justice issuing an order requesting the Twitter activity of several people involved with the organization, Order Flagyl. Flagyl steet value, Salon's Glenn Greenwald, who posted many of the order's details and a copy of the order itself, also wondered, "did other Internet and social network companies (Google, Facebook, etc.) receive similar Orders and then quietly comply?"
Remarkably, Twitter didn't just quietly comply. The order originally had a gag order preventing Twitter from telling the targets themselves that it was handing over their data, Flagyl brand name, but Twitter challenged it in court and got a new, unsealed order issued, then told the targets about it. Fast Company looked at the likely role of Twitter's attorney, Alexander Macgillivray, in challenging the order, Flagyl without a prescription, and Wired's Ryan Singel praised Twitter for standing up for its users against government, something that hasn't really been a norm among online companies.
Mashable's Vadim Lavrusik examined the potential implications of the order for journalists doing reporting on Twitter and other social media platforms, and Mathew Ingram of GigaOM noted that the episode illustrates how much we rely on single corporate networks within social media. Order Flagyl, The traditional news media, meanwhile, remains lukewarm at best toward WikiLeaks and its founder, Julian Assange, as McClatchy pointed out. At The Columbia Journalism Review, Craig Silverman broke down one manifestation of that cold shoulder — the way mainstream news organizations continue to incorrectly report that WikiLeaks has released hundreds of thousands of diplomatic cables, when it has actually released just 2,000, order Flagyl from mexican pharmacy.
Also on the WikiLeaks front, Assange claimed in an interview to have "insurance" files on Rupert Murdoch and his News Corp., and WikiLeaks attacked those who have called for Assange to be hunted down or killed. American WikiLeaks volunteer Jacob Applebaum tweeted about his being detained by the U.S. while re-entering the country, and was profiled by Rolling Stone. And Evgeny Morozov of Foreign Policy argued that WikiLeaks' cause would be best served if it would shift from leaking information to building a decentralized, open Internet infrastructure, Order Flagyl. Flagyl pics, —
Quora hits the scene: The sudden growth of the question-and-answer site Quora is a story that's been building for several weeks, but I thought now would be as good a time as any to get you up to speed on it. The buzz started just after Christmas, when tech guru Robert Scoble wondered whether it could be the next evolution of blogging. MG Siegler of the influential tech blog TechCrunch followed up by saying much the same thing, and talked about using Quora as inspiration for many of his TechCrunch posts. That week, it also received praise from Google's head of user interaction, order Flagyl from United States pharmacy, Irene Au. Order Flagyl, That was the nudge Quora needed to begin some seriously explosive growth, doubling its number of signups twice in about two weeks. Quora, which was founded in 2009 by two Facebook veterans, is a fairly simple site — just questions and answers, not unlike Yahoo Answers and Facebook Questions. But it's managed to keep the quality of questions and answers up, Flagyl dangers, and it's attracted a smart user base heavy on the "cool kids" of the tech world.
The next question, though, was how this rapid growth would shape Quora. The Telegraph's Milo Yiannopoulos predicted that it would get bigger than Twitter, though Vadim Lavrusik of Mashable saw it as more suited to niche communities: "Quora feels heavy, which is of course where it excels, providing in-depth commentary to questions, online Flagyl without a prescription. But that heaviness is unlikely to attract a large audience."
Mathew Ingram of GigaOM questioned whether Quora will be able to maintain its standard of quality as it grows, and Mary Hamilton wrote about Quora's struggles between what its admins want and what its user want, Order Flagyl. Meanwhile, Poynter's Mallary Jean Tenore explored several of the best ways for journalists to use Quora, including looking for ideas for local content and monitoring the buzz around an issue.
Reading roundup: I haven't given you any iPad updates yet, so you know this review can't quite be finished. Very well then:
— We're still talking about the decline of magazine app sales on the iPad, Flagyl australia, uk, us, usa, with The Guardian's Jemima Kiss looking at that disappointment and some publishers' efforts to overcome it. Advertising Age's Simon Dumenco called those sales declines meaningless, but designer Khoi Vinh urged those publishers to stop pouring their resources into print-like tablet products. Order Flagyl, The particular project that everyone's most interested in is Rupert Murdoch's The Daily, which will reportedly be launched next Wednesday with Murdoch and Steve Jobs on stage together. Rex Sorgatz heard that its companion website will have no homepage and be hidden from search engines, and Poynter's Damon Kiesow took a peek at the site's source code for clues.
— Wikipedia will turn 10 this weekend, and Pew kicked off the commemoration with a survey finding that 42% of American adults use Wikipedia to look up information. Mathew Ingram of GigaOM explained how Wikipedia set the prototype for modern information flow on the web, Flagyl reviews.
— Facebook announced this week that it will allow users to like individual authors and topics within sites. ReadWriteWeb's Marshall Kirkpatrick said it's a step toward Facebook being able to do what RSS feeds couldn't, Order Flagyl. Meanwhile, the Bivings Group looked at the top newspaper Facebook fan pages.
— One great piece I missed last week: Paul Ford conceptualized the web as a customer service medium, organized around the central question, "Why wasn't I consulted?" Ryan Sholin applied the concept to online reporting. Flagyl without prescription, — If you're interested in real-time editing and curation, this might be an experiment to watch: Quickish, launched this week by former ESPN-er Dan Shanoff, who is starting by applying that concept to sports commentary and hoping to expand to other areas.
— Finally, three bigger pieces to ponder over the weekend: Dan Gillmor's book excerpt at Salon on surviving the tsunami of information; Forbes' Lewis DVorkin's vision for the news site built on personally branded journalists; and the Lab's Ken Doctor on the metrics that will define news in 2011.
Similar posts: Buy Synthroid No Prescription. Diflucan Mg. Zoloft For Sale. Retin A coupon. Rx free Zoloft. No prescription Glucophage online.
Trackbacks from: Order Flagyl. Order Flagyl. Order Flagyl. Flagyl from canadian pharmacy. Where can i cheapest Flagyl online. Fast shipping Flagyl.
[This review was originally posted at the Nieman Journalism Lab Tramadol Over The Counter, on Jan. 7, 2011.]
A net neutrality compromise: The Review might have taken two weeks off for the holidays, but the rest of the future-of-news world kept on humming. Consider this more your "Holidays in Review" than your "Week in Review." Let's get to it.
The biggest news development of the past few weeks came just before Christmas, when the FCC passed a set of Internet regulations that were widely characterized as a compromise between net neutrality advocates and big Internet service providers. Tramadol pharmacy, In essence, the rules will keep ISPs from blocking or slowing services on the traditional wired Internet, but leave the future of wireless regulation more unclear. (Here's a copy of the order and a helpful explainer from GigaOM.)
In the political realm, the order drew predictable responses from both sides of the aisle: Conservatives (including at least one Republican FCC commissioner) were skeptical of a move toward net neutrality, while liberals (like Democratic Sen. Al Franken) fervently argued for it, Tramadol Over The Counter. In the media-tech world, it was greeted — as compromises usually are — with near-universal disdain. The Economist ran down the list of concerns for net neutrality proponents, led by the worry that the FCC "has handed the wireless carriers a free pass." This was especially troubling to j-prof Dan Kennedy, who argued that wireless networks will be far more important to the Internet's future than wired ones, Tramadol samples.
Salon's Dan Gillmor said the FCC paid lip service to net neutrality, paving the way for a future more like cable TV than the open web we have now. Newsweek's Dan Lyons compressed his problems with the order into one statement: "There will soon be a fast Internet for the rich and a slow Internet for the poor."
From the other side, Slate media critic Jack Shafer, a libertarian, questioned whether the FCC had the power to regulate the Internet at all, Order Tramadol no prescription, and imagined what the early Internet would have been like if the FCC had regulated it then. The Los Angeles Times' James Rainey told both sides Tramadol Over The Counter, to calm down, and at the Knight Digital Media Center, Amy Gahran used the story as an object lesson for news organizations in getting and linking to the source documents in question.
WikiLeaks and the media's awkward dance: The long tail of this fall's WikiLeaks story continues to run on, meandering into several different areas over the holidays. There are, of course, ongoing efforts to silence WikiLeaks, both corporate (Apple pulled the WikiLeaks app from its store) and governmental (a bill to punish circulation of similar classified information was introduced, and criticized by law prof Geoffrey Stone), online buying Tramadol.
In addition, Vanity Fair published a long piece examining the relationship between WikiLeaks' Julian Assange and The Guardian, the first newspaper to partner with him. Based on the story, Slate's Jack Shafer marveled at Assange's shrewdness and gamesmanship ("unequaled in the history of journalism"), Reuters' Felix Salmon questioned Assange's mental health, Buy cheap Tramadol, and The Atlantic's Nicholas Jackson wondered why The Guardian still seems to be playing by Assange's rules.
We also saw the blowup of Salon columnist Glenn Greenwald's feud with Wired over some chat logs between alleged WikiLeaks leaker Bradley Manning and the man who turned him in, Tramadol Over The Counter. It's a complicated fight I'm not going to delve into here, but if you'd like to know more, here are two good blow-by-blows, one more partial to Wired, and another more sympathetic to Greenwald.
Greenwald has also continued to be one of the people leading the inquiries into the traditional media's lack of support for WikiLeaks. Alternet rebutted several media misconceptions about WikiLeaks, rx free Tramadol, and Newsweek attempted to explain why the American press is so lukewarm on WikiLeaks — they aren't into advocacy, and they don't like Assange's purpose or methods. One of the central questions to that media cold-shoulder might be whether Assange is considered a journalist, something GigaOM's Mathew Ingram tried to tackle. Tramadol Over The Counter, Other, more open critiques of WikiLeaks continue to trickle out, including ones from author Jaron Lanier and Floyd Abrams, a lawyer who argued for The New York Times in the Pentagon Papers case. Abrams' argument prompted rebuttals from Jack Shafer and NYU prof Clay Shirky. Shirky in particular offered a nuanced comparison of the Pentagon Papers-era Times and the globally oriented WikiLeaks, concluding that "the old rules will not produce the old outcomes." If you're still hungry for WikiLeaks analysis, Tramadol trusted pharmacy reviews, John Bracken's rounded up the best of the year here.
Looking back, and looking forward: We rang in the new year last week, and that, of course, always means two things in the media world: year-end retrospectives, and previews of the year to come. The Lab wrapped up its own year in review/preview before Christmas with a review of Martin Langeveld's predictions for 2010. PBS' MediaShift also put together a good set of year-end reviews, order Tramadol online c.o.d, including ones on self-publishing, the rapidly shifting magazine industry, a top-ten list of media stories (led by WikiLeaks, Facebook, and the iPad). You can also get a pretty good snapshot of the media year that was by taking a look at AOL's list of the top tech writing of 2010.
Poynter's Rick Edmonds examined the year in newspaper stock prices (not great, but could've been worse), while media consultant Alan Mutter explained that investors tended to stay away from debt-laden newspaper companies in particular, Tramadol Over The Counter. Get Tramadol, As for the year to come, the Lab's readers weighed in — you like ProPublica, The Huffington Post, and Clay Shirky, and you're split on paywalls — and several others chimed in with their predictions, too. Among the more interesting prognostications: New York Times media critic David Carr sees tablets accelerating our ongoing media convergence, The Next Web forecasts a lot of blogs making the Gawker-esque beyond the blog format, online buy Tramadol without a prescription, Mashable's Vadim Lavrusik predicts the death of the foreign correspondent, TBD's Steve Buttry sees many journalism trade organizations merging, and the Lab's Martin Langeveld thinks we'll see John Paton's innovative measures at the Journal Register Co. slowly begin to be emulated elsewhere in the newspaper industry.
Two other folks went outside the predictions mold for their 2011 previews: media analyst Ken Doctor looked at 11 pieces of conventional wisdom the media industry will test this year, and the University of Colorado's Steve Outing outlined his wishes for the new year. Tramadol Over The Counter, Specifically, he wants to see News Corp. My Tramadol experience, and The New York Times' paid-content plans fail, and to see news execs try a value-added membership model instead. "This will require that news publishers actually work their butts off to sell, rather than sit back and expect people to fork over money "just because" everyone should support journalism," he wrote.
Rethinking publishing for the tablet: One theme for the new year in media that's already emerged is the impending dominance of the tablet. As The New York Times' Joshua Brustein wrote, that was supposed to be the theme last year, too, Tramadol recreational, but only the iPad was the only device able to get off the ground in any meaningful way. Several of Apple's competitors are gearing up to make their push this year instead; The Times' Nick Bilton predicted that companies that try to one-up Apple with bells and whistles will fail, though Google may come up with a legitimate iPad rival.
Google has begun work toward that end, looking for support from publishers to develop a newsstand to compete with Apple's app store, Tramadol Over The Counter. And Amazon's Kindle is doing fine despite the iPad's popularity, TechCrunch argued. Meanwhile, Tramadol from mexico, Women's Wear Daily reported that magazine app sales on the iPad are down from earlier in the year, though Mashable's Lauren Indvik argued that the numbers aren't as bad as they seem.
The magazine numbers prompted quite a bit of analysis of what's gone wrong with magazine apps. British entrepreneur Andrew Walkingshaw ripped news organizations for a lack of innovation in their tablet editions — "tablets are always-on, tactile, completely reconfigurable, great-looking, permanently jacked into the Internet plumbing, Tramadol results, and you’re using them to make skeumorphic newspaper clones?" — and French media consultant Frederic Filloux made similar points, urging publishers to come up with new design concepts and develop a coherent pricing structure (something Econsultancy's Patricio Robles had a problem with, too). Tramadol Over The Counter, There were plenty of other suggestions for tablet publications, too: GigaOM's Mathew Ingram said they should focus on filtering the web, MG Siegler of TechCrunch asked for an easy-to-use newsstand rather than a system of standalone apps, and Alan Mutter suggested magazines lower the prices and cut down on the technical glitches.
Three others focused specifically on the tablet publishing business model: At the Lab, Ken Doctor gave us three big numbers to watch in determining where this is headed, entrepreneur Bradford Cross proposed a more ad-based model revolving around connections to the open web, After Tramadol, and venture capitalist Fred Wilson predicted that the mobile economy will soon begin looking more like the web economy.
Reading roundup: A few items worth taking a look at over the weekend:
— The flare-up du jour in the tech world is over RSS, and specifically, whether or not it is indeed still alive. Web designer Kroc Camen suggested it might be dying, TechCrunch's MG Siegler fingered Twitter and Facebook as the cause, Dave Winer (who helped develop RSS) took umbrage, and GigaOM's Mathew Ingram and The Guardian's Martin Belam defended RSS' relevance.
— Add the Dallas Morning News to the list of paywalled (or soon-to-be-paywalled) papers to watch: It announced it will launch a paid-content plan Feb. 15, Tramadol Over The Counter. The Lab's Justin Ellis shed light on Morning News' thinking behind the plan. PaidContent's Staci Kramer alsobroke down a Pew report on paying for online content.
— For the many writers are considering how to balance social media and longer-form writing, two thoughtful pieces to take a look at: Wired's Clive Thompson on the way tweets and texts can work in concert in-depth analysis, and Anil Dash on the importance of blogging good ideas.
— Finally, NPR's Matt Thompson put together 10 fantastic lessons for the future of media, all coming from women who putting them into action. It's an encouraging, inspiring set of insights.
Similar posts: Purchase Cephalexin. Order Glucophage. Lipitor Price. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Tramadol Over The Counter. Tramadol Over The Counter. Tramadol Over The Counter. Tramadol natural. Tramadol pharmacy. Tramadol no rx.
—[This review was originally posted at the Nieman Journalism Lab Buy Cephalexin No Prescription, on Dec. 17, 2010.]
The media and WikiLeaks' uneasy coexistence: The current iteration of the WikiLeaks story is about to move into its fourth week, and it continues to swallow up most future-of-journalism news in its path. By now, it's branched out into several distinct facets, and we'll briefly track down each of those, but here are the essentials this week: If you want the basics, Cephalexin gel, ointment, cream, pill, spray, continuous-release, extended-release, Gawker has put together a wonderful explainer for you. If you want to dive deep into the minutiae, there's no better way than Dave Winer's wikiriver of relevant news feeds. Other good background info is this Swedish documentary on WikiLeaks, posted here in YouTube form.
The big news development this week was WikiLeaks founder Julian Assange's release from British jail on bail Thursday, Buy Cephalexin No Prescription. As blow-by-blow accounts of the legal situation go, Buy Cephalexin without prescription, you can't beat The Guardian's. Meanwhile, the U.S. government is trying to build a conspiracy case against Assange by connecting him more explicitly to Bradley Manning's leak, and Congress heard testimony on the subject Thursday.
— The first WikiLeaks substory is the ongoing discussion about the actions of the legions of web-based "hacktivists," led by Anonymous, making counterattacks on WikiLeaks' behalf, Cephalexin used for. Having gone after several sites last week (including one mistakenly Buy Cephalexin No Prescription, ), some activists began talking in terms of "cyber-war" — though GigaOM's Mathew Ingram cautioned against that type of language from all sides — and were urged on from jail by Assange. NYU professor Gabriella Coleman gave a glimpse into the inner workings of Anonymous, and they also drew plenty of criticism, too, from thinkers like British author Andrew Keen. Media consultant Deanna Zandt offered a thoughtful take on the ethics of cyber-activism.
— The second facet here is the emergence of Openleaks, Is Cephalexin safe, a leaking organization formally launched this week by WikiLeaks defector Daniel Domscheit-Berg as an alternative to Assange's group. As Domscheit-Berg explained to several outlets including Forbes, Openleaks will act as a more neutral conduit to leaks than WikiLeaks, which ended up publishing its leaks, something Openleaks won't do. Wired compared it with WikiLeaks' rejected 2009 Knight News Challenge proposal, in which it would have functioned primarily as an anonymous submission system for leaks to local news organizations, Buy Cephalexin No Prescription. Openleaks won't be the last, either: As The Economist noted, if file-sharing is any guide, Cephalexin coupon, we'll see scores of rivals (or comrades).
— The third story is the reaction of various branches of the traditional media, which have been decidedly mixed. WikiLeaks has gotten some support from several corners of the industry, including the faculty of the venerable Columbia School of Journalism, the press in Assange's native Australia, Cephalexin for sale, and Northeastern j-prof Dan Kennedy and numerous other British and American professors and journalists, both in The Guardian. But it's also been tweaked by others — New York Times editor Bill Keller said that if Assange is a journalist, "he's not the kind of journalist that I am."
Salon columnist Glenn Greenwald ripped what he called the mainstream media's "servile role" to the government in parroting its attitudes toward WikiLeaks, then later argued that the government's prosecution of WikiLeaks would be a prosecution of investigative journalism in general. Buy Cephalexin No Prescription, Likewise, Morris' Steve Yelvington listed five reasons the media hasn't shown outrage about the government's backlash against WikiLeaks, including the point that the segment of the American mainstream media concerned about national issues is a shell of its former self.
— All of this provided plenty of fodder for a couple of conferences on WikiLeaks, Internet freedom, and secrecy, what is Cephalexin. Last weekend, the Personal Democracy Forum held a symposium on the subject — you can watch a replay here, as well as a good summary by GRITtv and additional videos on the state of the Internet and online civil disobedience. Micah Sifry offered a thoughtful take on the event afterwards, saying that longings for a "more responsible" version of WikiLeaks might be naive: It's "far more likely that something far more disruptive to the current order--a distributed and unstoppable system for spreading information--is what is coming next," he wrote. Online buying Cephalexin hcl, And on Thursday, the Lab held its own one-day conference on journalism and secrecy that included keynotes by the AP's Kathleen Carroll and The Times' Bill Keller (who distanced himself from Assange but defended The Times' decision to publish). If you want to go deeper into the conversation at the conference, the #Niemanleaks hashtag on Twitter is a good place to start, Buy Cephalexin No Prescription.
Will the iPad eat into print?: The iPad news this week starts with the University of Missouri's Reynolds Journalism Institute, which released a study that suggests, based on survey data, that iPad news apps may cut into newspaper subscriptions by next year. There's a ton of other interesting data on how iPads are being used and how users are comparing them to print newspapers and newspaper websites, but one statistic — 58% of those who subscribe to a print newspaper and use their iPad for more than an hour a day planned to cancel their print subscription within six months — was what drew the headlines, buy generic Cephalexin. Alan Mutter said publishers have to like the demographics of the iPad's prime users, but have to wonder whether developing print-like iPad apps is worth it.
Several news organizations introduced new iPad apps this week, led by CNN. Poynter's Damon Kiesow talked to CNN Buy Cephalexin No Prescription, about the rationale behind its photo-oriented multitouch design, and MocoNews' Ingrid Lunden looked at why CNN might have made their app free. Steve Safran of Lost Remote liked the app's design and sociability. Also, Order Cephalexin online overnight delivery no prescription, the New York Daily News launched a paid (though cheaper than the New York Post) app, and Harper's added its own as well.
Meanwhile, Flipboard, the inaugural iPad app of the year, launched a new version this week. Forbes' Quentin Hardy talked to Flipboard's CEO about the vision behind the new app, and The Wall Street Journal wrote about innovative iPad news apps in general, cheap Cephalexin. The Washington Post's Justin Ferrell talked to the Lab's Justin Ellis about how to design news apps for the iPad, Buy Cephalexin No Prescription. In iPad advertising, Apple launched its first iAd, which seems to be essentially a fully formed advertisement app. One iPad app that's not coming out this week: Rupert Murdoch's "tablet newspaper" The Daily, whose launch has reportedly been postponed until next year.
Looking ahead to 2011: We're nearing the end of the December, Where can i cheapest Cephalexin online, which means we're about to see the year-end reviews and previews start to roll in. The Lab got them kicked off this week by asking its readers for predictions of what 2011 will bring in the journalism world, then publishing the predictions of some of the smartest future-of-news folks in the room. Buy Cephalexin No Prescription, All of the posts are worth checking out, but there are a few I want to note in particular — The AP's Jonathan Stray on moving beyond content tribalism ("a news product that refuses to provide me with high-quality filtering and curation of the rest of the world’s information will only ever be an endpoint"), NPR's Matt Thompson on instant speech transcription ("the Speakularity"), tech pioneer Dave Winer on adjusting to the new news distribution system ("That’s the question news people never seem to ask. How can we create something that has a market?"), and a couple of paid-content predictions on The New York Times and by Steven Brill (who has skin in the game).
The prediction post that generated the most discussion was NYU professor Clay Shirky's piece on the dismantling of the old-media syndication system. GigaOM's Mathew Ingram expanded on the idea, connecting it explicitly to Google News and the Associated Press, taking Cephalexin, and asking, "In a world where the power to syndicate is available to all, does anyone want what AP is selling?" USC's Pekka Pekkala explained why he sees this as a positive development for journalists and niche content producers.
As if on cue, Thomson Reuters announced the launch of its new American news service, one that seems as though it might combine traditional news syndication with some elements of modern aggregation. Media analyst Ken Doctor gave some more details about the new service and its deal with the Tribune Co., and Gawker's Hamilton Nolan was skeptical of this potential new direction for newswires, Buy Cephalexin No Prescription. Cephalexin natural, —
Reading roundup: A few good pieces before I send you on your way:
— First, one quick bit of news: The social bookmarking service Delicious will reportedly be shut down by Yahoo. Here's a short ode from ReadWriteWeb and a list of alternatives from The Next Web.
— At the London Review of Books, British journalist John Lanchester has written an essay making a case for why and how the newspaper industry needs to charge for news online. Anti-paywall folks aren't going to be crazy about it, but it's far from the stereotypical revanchist "Make 'em pay, just 'cause they should" pro-pay argument: "Make the process as easy as possible, no prescription Cephalexin online. Buy Cephalexin No Prescription, Make it invisible and transparent. Make us register once and once only. Walls are not the way forward, but walls are not the same thing as payment, and without some form of payment, the press will not be here in five years’ time."
— A couple of close looks at what news organizations are doing right: The Atlantic's web transformation and tips on multimedia storytelling from NPR's acclaimed Planet Money.
— A North Carolina j-prof and Duke grad student came together(!) to urge news organizations to incorporate more of the tenets of citizen journalism. They have a few specific, practical suggestions, too.
— British journalist Adam Westbrook gave his goodbye to mainstream media, making a smart case that the future lies outside its gates.
— Finally, Jonathan Stray, an AP editor and Lab contributor, has a brilliant essay challenging journalists and news organizations to develop a richer, more fully formed idea of what journalism is for. It may be a convicting piece, but it offers an encouraging vision for the future — and the opportunity for reform — too.
Similar posts: Flagyl For Sale. Bactrim Mg. Lipitor Cost. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Buy Cephalexin No Prescription. Buy Cephalexin No Prescription. Buy Cephalexin No Prescription. Cephalexin forum. Order Cephalexin from United States pharmacy. Buy Cephalexin online no prescription.